Literature DB >> 19908085

CT-guided fiducial placement for cyberknife stereotactic radiosurgery: an initial experience.

Evangelia Sotiropoulou1, Iotarene Stathochristopoulou, Konstantinos Stathopoulos, Kosmas Verigos, Nikolaos Salvaras, Loukas Thanos.   

Abstract

CyberKnife frameless image-guided radiosurgery has become a widely used system for parenchymal extracranial lesions. Gold fiducials are required for the planning and aiming of CyberKnife therapy. We report our initial experience and describe the technique of positioning tumor markers, under CT guidance. We conducted a retrospective review of 105 patients who were referred for CyberKnife stereotactic radiosurgery at Iatropolis CyberKnife Center in Athens. All patients underwent percutaneous fiducial placement via CT guidance. At the desired location, the 18-G needle was advanced into or near the tumor. Data collected included number and locations of fiducials placed and complications experienced to date. One hundred five patients underwent fiducial placement under CT guidance and a total number of 319 gold seeds were implanted. We experienced one episode of pneumothorax that required drainage, one mild pneumothorax, and three episodes of perifocal pulmonary hemorrhage. In conclusion, fiducial implantation under CT guidance appears to be a safe and efficient procedure, as long as it is performed by an experienced interventional radiologist.

Entities:  

Mesh:

Year:  2009        PMID: 19908085     DOI: 10.1007/s00270-009-9748-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  8 in total

1.  Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study.

Authors:  Maria Marsico; Tommaso Gabbani; Lorenzo Livi; Maria Rosa Biagini; Andrea Galli
Journal:  World J Hepatol       Date:  2016-06-18

2.  Technical note: Image guided internal fiducial placement for stereotactic radiosurgery (CyberKnife).

Authors:  Govindarajan Janardan Mallarajapatna; Sridhar Papaiah Susheela; Kumar Gangadharaiah Kallur; Nagaraj Kanakapura Ramanna; Prashant Guthlu Ramachandra; Shivakumar Swamy Shivalingappa
Journal:  Indian J Radiol Imaging       Date:  2011-01

3.  Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor.

Authors:  Jingsheng Wang; Fengtong Li; Yang Dong; Yongchun Song; Zhiyong Yuan
Journal:  Onco Targets Ther       Date:  2016-07-15       Impact factor: 4.147

4.  Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience.

Authors:  Kengo Ohta; Masashi Shimohira; Hiromitsu Iwata; Takuya Hashizume; Hiroyuki Ogino; Akifumi Miyakawa; Taro Murai; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2013-04-21       Impact factor: 2.724

5.  Safety and efficacy of ultrasound-guided fiducial marker implantation for CyberKnife radiation therapy.

Authors:  Jae Hyun Kim; Seong Sook Hong; Jung Hoon Kim; Hyun Jeong Park; Yun-Woo Chang; A Ram Chang; Seok-Beom Kwon
Journal:  Korean J Radiol       Date:  2012-04-17       Impact factor: 3.500

6.  Treating adrenal tumors in 26 patients with CyberKnife: a mono-institutional experience.

Authors:  Jing Li; Zhaorong Shi; Zhen Wang; Zhibing Liu; Xinhu Wu; Zetian Shen; Bing Li; Yong Song; Xixu Zhu
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

7.  Stability of percutaneously implanted markers for lung stereotactic radiotherapy.

Authors:  Gitte F Persson; Mirjana Josipovic; Peter von der Recke; Marianne C Aznar; Trine Juhler-Nøttrup; Per Munck af Rosenschöld; Stine Korreman; Lena Specht
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

8.  Automatic patient positioning and gating window settings in respiratory-gated stereotactic body radiation therapy for pancreatic cancer using fluoroscopic imaging.

Authors:  Niclas Pettersson; Daniel Simpson; Todd Atwood; Jona Hattangadi-Gluth; James Murphy; Laura Cerviño
Journal:  J Appl Clin Med Phys       Date:  2018-01-27       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.